Allarity Therapeutics Reports First Quarter 2022 Financial Results
May 27, 2022 17:37 ET
|
Allarity Therapeutics, Inc.
Cambridge, MA U.S.A. (May 27, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with...
Akerna Announces Corporate Restructuring
May 27, 2022 17:30 ET
|
Akerna Corp.
DENVER, May 27, 2022 (GLOBE NEWSWIRE) -- Akerna Corp. (Nasdaq: KERN) (“Akerna”), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures,...
Nuvei Corporation Announces Annual and Special Meeting Results
May 27, 2022 17:17 ET
|
Nuvei Corporation
MONTREAL, May 27, 2022 (GLOBE NEWSWIRE) -- Nuvei Corporation (the “Corporation”) (Nasdaq: NVEI) (TSX: NVEI), tomorrow’s payment platform, today announced the results of its annual and special...
Corporation Nuvei annonce les résultats du scrutin tenu lors de son assemblée annuelle et extraordinaire
May 27, 2022 17:17 ET
|
Nuvei Corporation
MONTRÉAL, 27 mai 2022 (GLOBE NEWSWIRE) -- Corporation Nuvei (la « Société ») (Nasdaq : NVEI) (TSX : NVEI), la plateforme de paiement de demain, a annoncé aujourd’hui les résultats du scrutin...
UTime Limited Announces Appointment of Weiyuan Wang to Board of Directors
May 27, 2022 17:00 ET
|
UTIME LTD
SHENZHEN, CHINA, May 27, 2022 (GLOBE NEWSWIRE) -- UTime Limited (NASDAQ: UTME) (“UTime”), a mobile device manufacturing company focused on China and other emerging markets, today announced that the...
Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules
May 27, 2022 16:30 ET
|
Alector, Inc.
SOUTH SAN FRANCISCO, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the compensation...
Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q
May 27, 2022 16:30 ET
|
Brooklyn ImmunoTherapeutics, Inc.
SAN DIEGO, May 27, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and...
NVIDIA Recommends Stockholders Reject ‘Mini-Tender’ Offer by Tutanota LLC
May 27, 2022 16:20 ET
|
NVIDIA
SANTA CLARA, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- NVIDIA today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC to purchase up to 215,000 shares of...
Firsthand Technology Value Fund Discloses Top Portfolio Holdings
May 27, 2022 16:15 ET
|
Firsthand Technology Value Fund, Inc.
SAN JOSE, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech...
Synchronoss Technologies, Inc. Reports Inducement Grants to Employees Under Nasdaq Listing Rule 5635(c)(4)
May 27, 2022 16:05 ET
|
Synchronoss Technologies, Inc.
BRIDGEWATER, N.J., May 27, 2022 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and digital...